Search Results 141-150 of 28433 for B cell lymphomas
Study Of Nivolumab In Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed Or Are Not Eligible For Autologous Stem ...
... B-cell lymphomas. Clinically, four weekly doses of rituximab have proven to ... Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma ( ...
... B-Cell Lymphoma Subtype Defined by the Cell of Origin. ... Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young ...
Developing the first genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non-Hodgkin ...
Find out more about the symptoms, diagnosis and treatment of this type of non-Hodgkin lymphoma.
... B-cell non-Hodgkin lymphoma (NHL) subtypes of diffuse large B-cell lymphoma (DLBCL) and Grade 3 follicular lymphoma (FL3). Additionally, the pharmacokinetic ...
A Study Of Itacitinib (INCB039110) In Combination With Ibrutinib In Subjects With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma ... B-cell lymphoma (DLBCL) ...
Study Of Iopofosine I 131 (CLR 131) In Select B-Cell ... This study evaluates CLR 131 in patients with select B-cell ... Patients with Mantle Cell Lymphoma. Prior ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.